Amyloid imaging in mild cognitive impairment subtypes

Objective We utilized the amyloid imaging ligand Pittsburgh Compound B (PiB) to determine the presence of Alzheimer's disease (AD) pathology in different mild cognitive impairment (MCI) subtypes and to relate increased PiB binding to other markers of early AD and longitudinal outcome. Methods T...

Full description

Saved in:

Bibliographic Details
Published in:	Annals of neurology Vol. 65; no. 5; pp. 557 - 568
Main Authors:	Wolk, David A., Price, Julie C., Saxton, Judy A., Snitz, Beth E., James, Jeffrey A., Lopez, Oscar L., Aizenstein, Howard J., Cohen, Ann D., Weissfeld, Lisa A., Mathis, Chester A., Klunk, William E., DeKosky, Steven T.
Format:	Journal Article
Language:	English
Published:	Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.05.2009 Wiley-Liss
Subjects:	Aged Aged, 80 and over Amyloid - metabolism Aniline Compounds Biological and medical sciences Brain Mapping Cognition Disorders - classification Cognition Disorders - diagnostic imaging Cognition Disorders - pathology Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Female Follow-Up Studies Hippocampus - diagnostic imaging Hippocampus - pathology Humans Magnetic Resonance Imaging - methods Male Medical sciences Middle Aged Neurology Neuropsychological Tests Positron-Emission Tomography - methods Psychometrics - methods Thiazoles Nervous system diseases Amyloid mild cognitive impairment Cognitive disorder Subtype
ISSN:	0364-5134, 1531-8249, 1531-8249
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!